(Q46165669)

20 December 2017

title

Superoxide dismutase and cytokines in chronic patients with schizophrenia: association with psychopathology and response to antipsychotics (English)

1 reference

20 December 2017

1 reference

Xiang Yang Zhang

1

1 reference

20 December 2017

Dong Feng Zhou

2

1 reference

20 December 2017

Ling Yan Qi

3

1 reference

20 December 2017

Song Chen

4

1 reference

20 December 2017

Lian Yuan Cao

5

1 reference

20 December 2017

Da Chun Chen

6

1 reference

20 December 2017

Mei Hong Xiu

7

1 reference

20 December 2017

Fan Wang

8

1 reference

20 December 2017

Gui Ying Wu

9

1 reference

20 December 2017

Lin Lu

10

1 reference

20 December 2017

Therese A Kosten

11

1 reference

20 December 2017

Thomas R Kosten

12

1 reference

20 December 2017

publication date

13 January 2009

1 reference

20 December 2017

published in

Psychopharmacology

1 reference

20 December 2017

volume

204

1 reference

20 December 2017

issue

1

1 reference

20 December 2017

page(s)

177-184

1 reference

20 December 2017

https://scigraph.springernature.com/pub.10.1007/s00213-008-1447-6

exact match

0 references

cites work

The role of serotonin in schizophrenia

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00213-008-1447-6

Oxygen radicals and neuropsychiatric illness. Some speculations

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00213-008-1447-6

The role of immune function in schizophrenia: an overview

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00213-008-1447-6

Nuclear factor kappa B: an oxidative stress-responsive transcription factor of eukaryotic cells (a review)

21 January 2018

1 reference

12 December 2020

Elevated interleukin-2, interleukin-6 and interleukin-8 serum levels in neuroleptic-free schizophrenia: association with psychopathology.

1 reference

12 December 2020

Pharmacology of risperidone (R 64 766), a new antipsychotic with serotonin-S2 and dopamine-D2 antagonistic properties.

1 reference

12 December 2020

Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding

1 reference

12 December 2020

Free radical pathology and antioxidant defense in schizophrenia: a review

1 reference

12 December 2020

Membrane polyunsaturated fatty acids and CSF cytokines in patients with schizophrenia

1 reference

12 December 2020

Cytokine production in drug-free and neuroleptic-treated schizophrenic patients

1 reference

12 December 2020

Interleukin-2 and interleukin-6 in schizophrenia and mania: Effects of neuroleptics and mood stabilizers

1 reference

12 December 2020

Decreased in vitro production of interferon-gamma and interleukin-2 in whole blood of patients with schizophrenia during treatment

1 reference

12 December 2020

The Nithsdale Schizophrenia Surveys. XIV: Plasma lipid peroxide and serum vitamin E levels in patients with and without tardive dyskinesia, and in normal subjects

1 reference

12 December 2020

Enzymes of the antioxidant defense system in chronic schizophrenic patients

1 reference

12 December 2020

Mitogen-stimulated interleukin-2 production in never-medicated, first-episode schizophrenic patients. The influence of age at onset and negative symptoms

1 reference

12 December 2020

Elevated blood superoxide dismutase in neuroleptic-free schizophrenia: association with positive symptoms.

1 reference

12 December 2020

Cytokines and the brain: implications for clinical psychiatry

1 reference

12 December 2020

Increased indices of free radical activity in the cerebrospinal fluid of patients with tardive dyskinesia

1 reference

12 December 2020

Effects of haloperidol on antioxidant defense system enzymes in schizophrenia.

1 reference

12 December 2020

Serum interleukin-6 concentration in schizophrenia: elevation associated with duration of illness

1 reference

12 December 2020

Evidence that the activities of erythrocyte free radical scavenging enzymes and the products of lipid peroxidation are increased in different forms of schizophrenia

1 reference

12 December 2020

Some antioxidants inhibit, in a co-ordinate fashion, the production of tumor necrosis factor-alpha, IL-beta, and IL-6 by human peripheral blood mononuclear cells

1 reference

12 December 2020

Cytokine-specific central monoamine alterations induced by interleukin-1, -2 and -6.

1 reference

12 December 2020

Phospholipid patterns of erythrocytes in schizophrenia: relationships to symptomatology.

1 reference

12 December 2020

In vivo immunomodulatory effects of clozapine in schizophrenia

1 reference

12 December 2020

Blood superoxide dismutase level in schizophrenic patients with tardive dyskinesia: association with dyskinetic movements

1 reference

12 December 2020

Dopamine receptors and the dopamine hypothesis of schizophrenia

1 reference

12 December 2020

Essential fatty acid deficiency in erythrocyte membranes from chronic schizophrenic patients, and the clinical effects of dietary supplementation

1 reference

12 December 2020

Relationships between interleukins, neurotransmitters and psychopathology in drug-free male schizophrenics

1 reference

12 December 2020

Elevated CSF levels of interleukin-2 in neuroleptic-free schizophrenic patients

1 reference

12 December 2020

Free radical involvement in neuropsychiatric illnesses

1 reference

12 December 2020

Requirement for prooxidant and antioxidant states in T cell mediated immune responses. — Relevance for the pathogenetic mechanism of AIDS?

1 reference

12 December 2020

Red blood cell membrane dynamics in schizophrenia. III. Correlation of fatty acid abnormalities with clinical measures

1 reference

12 December 2020

Impaired antioxidant defense at the onset of psychosis.

1 reference

12 December 2020

A role for interleukin-2 in the regulation of striatal dopaminergic function

1 reference

12 December 2020

1 reference

12 December 2020

Reactive oxygen intermediates as second messengers of a general pathogen response.

1 reference

12 December 2020

Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1

1 reference

12 December 2020

Elevated interleukin-6 in schizophrenia

1 reference

12 December 2020

Immunosuppressive effects of clozapine and haloperidol: enhanced production of the interleukin-1 receptor antagonist

1 reference

12 December 2020

Effects of atypical antipsychotics on the inflammatory response system in schizophrenic patients resistant to treatment with typical neuroleptics.

1 reference

12 December 2020

Antioxidants inhibit the in vitro production of inflammatory cytokines in Crohn's disease and ulcerative colitis

1 reference

12 December 2020

Oxidant-antioxidant status in human immunodeficiency virus infection

1 reference

12 December 2020

Cytokine profiles in drug-naive schizophrenic patients

1 reference

12 December 2020

Increases in CSF levels of interleukin-2 in schizophrenia: effects of recurrence of psychosis and medication status

1 reference

12 December 2020

Fatty acid levels in the brains of schizophrenics and normal controls.

1 reference

12 December 2020

The inflammatory response system in treatment-resistant schizophrenia: increased serum interleukin-6.

1 reference

12 December 2020

Depleted red cell membrane essential fatty acids in drug-treated schizophrenic patients

1 reference

12 December 2020

Elevated plasma lipid peroxides at the onset of nonaffective psychosis

1 reference

12 December 2020

Free radical pathology in schizophrenia: a review

1 reference

12 December 2020

Acute-phase proteins and other systemic responses to inflammation

1 reference

12 December 2020

Plasma levels of cytokines and soluble cytokine receptors during treatment with haloperidol

1 reference

12 December 2020

Oxidative damage and schizophrenia: an overview of the evidence and its therapeutic implications

1 reference

12 December 2020

Smoking and schizophrenia

1 reference

12 December 2020

Risperidone versus haloperidol in the treatment of acute exacerbations of chronic inpatients with schizophrenia: a randomized double-blind study

1 reference

12 December 2020

10.1007/S00213-008-1447-6

Identifiers

DOI

1 reference

20 December 2017

1 reference

20 December 2017